- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Volitionrx Ltd (VNRX)
Volitionrx Ltd stock price live, this page displays NYSE VNRX stock exchange data. View the VNRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Volitionrx Ltd real time stock price chart below.
What Is the Volitionrx Ltd Stock Price Today?
The Volitionrx Ltd stock price today is 0.668.
What Is the Stock Symbol for Volitionrx Ltd?
The stock symbol for Volitionrx Ltd is ""VNRX.""
What Stock Exchange Does Volitionrx Ltd Trade On?
Volitionrx Ltd is listed and trades on the NYSE stock exchange.
Is Volitionrx Ltd a Good Stock to Buy?
Determining whether Volitionrx Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VNRX quote. (ISIN: US9286611077)
What Is the Volitionrx Ltd Stock Price Today?
The Volitionrx Ltd stock price today is 0.668.
What Is the Stock Symbol for Volitionrx Ltd?
The stock symbol for Volitionrx Ltd is ""VNRX.""
What Stock Exchange Does Volitionrx Ltd Trade On?
Volitionrx Ltd is listed and trades on the NYSE stock exchange.
Is Volitionrx Ltd a Good Stock to Buy?
Determining whether Volitionrx Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the VNRX quote. (ISIN: US9286611077)
NYSE
Currency in USD
0.668
+0.028(+4.38%)
Closed·
After Hours
0.640-0.028(-4.19%)
·
Fair Value
An estimate of a Volitionrx Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.600
0.675
52 wk Range
0.395
0.940
VNRX Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
Earnings results expected in 6 days
1/2
Fair Value
An estimate of a Volitionrx Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.6000.675
52 wk Range
0.3950.940
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
VNRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Volitionrx Ltd's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
2.940
Upside
+340.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Volitionrx Ltd Company Profile
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient’s cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Volitionrx Ltd Earnings Call Summary for Q1/2025
- VolitionRx Q1 2025 EPS: -$0.06 (missed -$0.04 forecast); Revenue: $250,000 (below $1.31M expected); Stock up 2.86% premarket despite miss
- Operating expenses down 35% YoY; Company aims for cash neutrality by 2025; Expects to double Nu.Q Discover revenue
- Pursuing multiple human licensing agreements; In talks with pharma companies for precision medicine applications
- Cash and equivalents at $2.6M; Net cash used in operations decreased 48% YoY; Current ratio at 0.52 indicates liquidity concerns
- CEO highlights progress in commercialization; Company focused on securing licensing deals in human diagnostics space
Last Updated: 16/05/2025, 14:14
Read Full TranscriptCompare VNRX to Peers and Sector
Metrics to compare | VNRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVNRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.9x | −3.4x | −0.5x | |
PEG Ratio | −0.07 | −0.19 | 0.00 | |
Price/Book | −2.5x | 2.5x | 2.6x | |
Price / LTM Sales | 52.6x | 3.7x | 3.3x | |
Upside (Analyst Target) | 329.7% | 28.3% | 42.8% | |
Fair Value Upside | Unlock | 4.2% | 6.5% | Unlock |
Analyst Ratings
5 Buy
1 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 2.940
(+340.12% Upside)
Earnings
Latest Release
May 16, 2025
EPS / Forecast
-0.06 / -0.04
Revenue / Forecast
250.00K / 1.31M
People Also Watch
FAQ
What Stock Exchange Does Volitionrx Ltd Trade On?
Volitionrx Ltd is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Volitionrx Ltd?
The stock symbol for Volitionrx Ltd is "VNRX."
What Is the Volitionrx Ltd Market Cap?
As of today, Volitionrx Ltd market cap is 67.99M.
What Is Volitionrx Ltd's Earnings Per Share (TTM)?
The Volitionrx Ltd EPS (TTM) is -0.27.
When Is the Next Volitionrx Ltd Earnings Date?
Volitionrx Ltd will release its next earnings report on 12 Aug 2025.
From a Technical Analysis Perspective, Is VNRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Volitionrx Ltd Stock Split?
Volitionrx Ltd has split 0 times.
How Many Employees Does Volitionrx Ltd Have?
Volitionrx Ltd has 82 employees.
What is the current trading status of Volitionrx Ltd (VNRX)?
As of 06 Aug 2025, Volitionrx Ltd (VNRX) is trading at a price of 0.67, with a previous close of 0.64. The stock has fluctuated within a day range of 0.60 to 0.68, while its 52-week range spans from 0.40 to 0.94.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.